Pediatrix Medical Group (NYSE:MD) Stock Price Crosses Above 200-Day Moving Average - Here's Why

Pediatrix Medical Group, Inc. (NYSE:MD - Get Free Report)'s share price passed above its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $12.44 and traded as high as $14.00. Pediatrix Medical Group shares last traded at $13.91, with a volume of 288,192 shares trading hands.

Analyst Ratings Changes

Several brokerages have issued reports on MD. UBS Group increased their price target on Pediatrix Medical Group from $10.50 to $16.50 and gave the stock a "neutral" rating in a report on Tuesday, November 5th. Mizuho increased their target price on Pediatrix Medical Group from $13.00 to $15.00 and gave the stock a "neutral" rating in a report on Tuesday, November 19th. Macquarie initiated coverage on shares of Pediatrix Medical Group in a research note on Monday, December 16th. They set an "outperform" rating and a $18.00 price target for the company. Deutsche Bank Aktiengesellschaft upped their price objective on shares of Pediatrix Medical Group from $9.00 to $15.00 and gave the stock a "hold" rating in a report on Monday, November 4th. Finally, StockNews.com upgraded shares of Pediatrix Medical Group from a "hold" rating to a "buy" rating in a report on Wednesday, January 22nd. Four investment analysts have rated the stock with a hold rating and three have given a buy rating to the company's stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus target price of $16.25.

Pediatrix Medical Group Trading Down 0.5 %

The company has a debt-to-equity ratio of 0.83, a quick ratio of 1.42 and a current ratio of 1.42. The firm has a market capitalization of $1.17 billion, a P/E ratio of -4.46, a PEG ratio of 1.38 and a beta of 1.57. The firm has a 50 day simple moving average of $13.87 and a two-hundred day simple moving average of $12.54.

Insider Activity

In related news, Director Mark S. Ordan sold 27,600 shares of the company's stock in a transaction that occurred on Wednesday, November 13th. The stock was sold at an average price of $15.35, for a total value of $423,660.00. Following the transaction, the director now owns 138,683 shares in the company, valued at approximately $2,128,784.05. This represents a 16.60 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 2.00% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in MD. State Street Corp increased its holdings in Pediatrix Medical Group by 1.4% in the 3rd quarter. State Street Corp now owns 3,540,791 shares of the company's stock worth $41,038,000 after acquiring an additional 50,597 shares during the last quarter. Nordea Investment Management AB boosted its holdings in Pediatrix Medical Group by 51.6% in the 4th quarter. Nordea Investment Management AB now owns 263,633 shares of the company's stock worth $3,504,000 after buying an additional 89,739 shares during the period. Barclays PLC lifted its position in shares of Pediatrix Medical Group by 302.9% during the third quarter. Barclays PLC now owns 142,087 shares of the company's stock worth $1,646,000 after acquiring an additional 106,817 shares in the last quarter. Franklin Resources Inc. purchased a new position in shares of Pediatrix Medical Group in the third quarter valued at $598,000. Finally, Principal Financial Group Inc. raised its stake in shares of Pediatrix Medical Group by 14.1% during the 3rd quarter. Principal Financial Group Inc. now owns 513,618 shares of the company's stock valued at $5,953,000 after purchasing an additional 63,581 shares during the period. Hedge funds and other institutional investors own 97.71% of the company's stock.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.